R 
2,788
+0.54%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in JPY, from our data supplier.
Revenue
¥28.50bn
FY2017FY2026
Net income
¥3.35bn
FY2017FY2026
Free cash flow
¥3.56bn
FY2017FY2026
Shareholders' equity
¥34.80bn
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ¥28.50bn | ¥27.88bn | ¥25.73bn | ¥23.87bn | ¥22.64bn | ¥20.47bn | ¥21.47bn | ¥21.29bn | ¥20.35bn | ¥19.19bn |
| Gross profit | ¥13.98bn | ¥15.35bn | ¥14.33bn | ¥12.69bn | ¥12.22bn | ¥11.11bn | ¥12.00bn | ¥12.11bn | ¥11.71bn | ¥10.86bn |
| Research and development | ¥843.2m | ¥2.14bn | ¥2.24bn | ¥1.90bn | ¥1.77bn | ¥1.65bn | ¥1.84bn | ¥1.83bn | ¥1.82bn | ¥1.77bn |
| Operating income | ¥4.36bn | ¥4.03bn | ¥3.47bn | ¥2.84bn | ¥3.10bn | ¥2.22bn | ¥2.49bn | ¥2.70bn | ¥2.56bn | ¥1.87bn |
| Net income | ¥3.35bn | ¥2.86bn | ¥2.65bn | ¥1.80bn | ¥2.23bn | ¥1.64bn | ¥1.78bn | ¥2.00bn | ¥1.89bn | ¥1.41bn |
| Diluted earnings per share | 271.33 | 231.93 | 215.30 | 146.18 | 181.23 | 133.18 | 144.85 | 163.14 | 153.76 | 114.72 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | ¥41.78bn | ¥39.13bn | ¥37.40bn | ¥34.81bn | ¥33.42bn | ¥30.68bn | ¥29.85bn | ¥28.48bn | ¥27.80bn | ¥25.92bn |
| Cash and short-term investments | ¥8.56bn | ¥6.01bn | ¥5.03bn | ¥5.37bn | ¥7.72bn | ¥6.44bn | ¥6.07bn | ¥4.55bn | ¥4.18bn | ¥3.66bn |
| Total liabilities | ¥6.98bn | ¥7.70bn | ¥8.19bn | ¥8.20bn | ¥8.14bn | ¥6.96bn | ¥7.62bn | ¥7.43bn | ¥8.22bn | ¥7.96bn |
| Debt | — | ¥11.7m | ¥21.9m | ¥28.5m | ¥40.1m | ¥53.0m | ¥66.5m | ¥46.0m | ¥103.1m | ¥552.5m |
| Shareholders' equity | ¥34.80bn | ¥31.44bn | ¥29.21bn | ¥26.61bn | ¥25.29bn | ¥23.73bn | ¥22.23bn | ¥21.04bn | ¥19.57bn | ¥17.96bn |
| Shares outstanding | 12m | 12m | 12m | 12m | 12m | 12m | 12m | 12m | 12m | 12m |
Cash flow
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | ¥4.17bn | ¥3.44bn | ¥2.86bn | ¥1.78bn | ¥2.84bn | ¥2.06bn | ¥2.70bn | ¥1.66bn | ¥1.92bn | ¥2.17bn |
| Capital spending | −¥602.6m | −¥1.30bn | −¥2.13bn | −¥2.06bn | −¥1.09bn | −¥1.12bn | −¥631.5m | −¥649.7m | −¥572.0m | −¥410.5m |
| Free cash flow | ¥3.56bn | ¥2.14bn | ¥726.0m | −¥279.1m | ¥1.76bn | ¥943.1m | ¥2.07bn | ¥1.02bn | ¥1.35bn | ¥1.76bn |
| Dividends paid | −¥948.0m | −¥738.7m | −¥553.6m | −¥565.6m | −¥528.9m | −¥552.9m | −¥515.1m | −¥467.3m | −¥368.8m | −¥368.5m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ¥6.89bn | ¥7.95bn | ¥6.93bn | ¥6.99bn | ¥6.63bn | ¥7.39bn | ¥7.45bn | ¥6.69bn |
| Gross profit | ¥3.41bn | ¥3.76bn | ¥3.45bn | ¥3.51bn | ¥3.27bn | ¥3.54bn | ¥3.75bn | ¥3.40bn |
| Operating income | ¥988.7m | ¥1.30bn | ¥1.08bn | ¥1.16bn | ¥829.6m | ¥964.3m | ¥1.31bn | ¥1.07bn |
| Net income | ¥687.9m | ¥1.10bn | ¥797.1m | ¥856.2m | ¥595.1m | ¥730.8m | ¥931.3m | ¥796.9m |
| Diluted earnings per share | 55.79 | 88.99 | 64.64 | 69.44 | 48.27 | 59.27 | 75.59 | 64.69 |
| Total assets | ¥42.80bn | ¥41.78bn | ¥39.58bn | ¥39.67bn | ¥38.98bn | ¥39.13bn | ¥38.31bn | ¥38.19bn |
| Cash and short-term investments | ¥9.87bn | ¥8.56bn | ¥7.86bn | ¥7.38bn | ¥6.16bn | ¥6.01bn | ¥4.93bn | ¥5.82bn |
| Debt | — | — | — | — | — | ¥6.6m | — | — |
| Shareholders' equity | ¥35.24bn | ¥34.80bn | ¥33.07bn | ¥32.56bn | ¥31.62bn | ¥31.44bn | ¥30.53bn | ¥30.10bn |
Financial ratios
Data as of 21 Sept 2026
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|---|
| Gross margin | 49.1% | 55.1% | 55.7% | 53.2% | 54.0% | 54.3% | — |
| Operating margin | 15.3% | 14.5% | 13.5% | 11.9% | 13.7% | 10.9% | — |
| Net margin | 11.7% | 10.3% | 10.3% | 7.5% | 9.8% | 8.0% | — |
| Return on equity | 9.6% | 9.1% | 9.1% | 6.8% | 8.8% | 6.9% | — |
| Return on assets | 8.0% | 7.3% | 7.1% | 5.2% | 6.7% | 5.3% | — |
| Free cash flow yield | 11.9% | 11.8% | 12.5% | 9.6% | 9.8% | 8.0% | — |
| Revenue growth | 2.2% | 8.4% | 7.8% | 5.4% | 10.6% | -4.7% | — |
| Earnings growth | 17.0% | 7.8% | 47.4% | -19.3% | 36.2% | -8.0% | — |
| Current ratio | 5.43x | 4.16x | 3.87x | 4.07x | 4.44x | 4.74x | — |
| Debt to equity | — | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Equity ratio | 83.3% | 80.3% | 78.1% | 76.4% | 75.7% | 77.3% | — |
| Interest coverage | 1863.29x | 1869.32x | 1786.58x | 1335.97x | 1603.82x | 1559.48x | — |
| R&D as a share of sales | 3.0% | 7.7% | 8.7% | 8.0% | 7.8% | 8.0% | — |
| Buybacks as a share of market value | 0.0% | -0.1% | -0.1% | -0.1% | -0.1% | -0.0% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 6.1% | 6.8% | 4.2% |
| Operating income | 15.3% | 14.5% | 6.8% |
| Net income | 23.0% | 15.4% | 7.7% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 52.0% | 53.2% | 53.5% | 54.7% |
| Operating margin | 14.9% | 13.9% | 13.4% | 12.8% |
| Net margin | 11.0% | 10.1% | 9.7% | 9.3% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 10.7 | 11.3 | 12.2 | 16.7 | 10.2 | 17.7 | 24.9 | 19.5 | 11.2 | 19.5 |
| Price to sales | 1.3 | 1.2 | 1.3 | 1.3 | 1.0 | 1.4 | 2.1 | 1.8 | 1.0 | 1.4 |
Dividends and splits
Per share, in the currency the company pays
Paid for 33 years. Last went ex-dividend on 29 Sept 2026.
| FY2027 | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 45.00 | 122.00 | 55.00 | 45.00 | 46.00 | 43.00 | 45.00 | 42.00 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.